Description
COST PER TEST IMMUNOASSAY TESTING
First action · last action
2013-10-03 · 2013-12-31
Transactions
2
First transaction's obligation
$63,619
Base + all options value (sum of deltas)
$58,719
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
SMALL BUSINESS SET ASIDE - TOTAL
Offers received
1
SDVOSB flag on record
No
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-03+$63,619= $63,619
- Mod P000012013-12-31-$4,900= $58,719
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-03 | +$63,619 | $63,619 | COST PER TEST IMMUNOASSAY TESTING |
| Mod P00001· FUNDING ONLY ACTION | 2013-12-31 | −$4,900 | $58,719 | COST PER TEST IMMUNOASSAY TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D48FNWJCJ5H5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026F0037 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $364,000 | FY2026 |
| 36C26026F0019 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $111,000 | FY2026 |
| 36C26026F0015 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $120,000 | FY2026 |
| 36C26025F0153 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $97,176 | FY2025 |
| 36C26025F0037 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C26325F0017 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $103,293 | FY2025 |
Other recipients under 6640 from 248-NETWORK CONTRACT OFFICE 8 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24816P2807 | HUNT OPTICS & IMAGING INC | 248-NETWORK CONTRACT OFFICE 8 | $14,458 | FY2016 |
| VA24816P2283 | BIOMERIEUX SA | 248-NETWORK CONTRACT OFFICE 8 | $7,938 | FY2016 |
| VA24816P1016 | L1 ENTERPRISES INCORPORATED | 248-NETWORK CONTRACT OFFICE 8 | $16,485 | FY2016 |
| VA24816P0987 | LEEDS PRECISION INSTRUMENTS INC | 248-NETWORK CONTRACT OFFICE 8 | $11,542 | FY2016 |
| VA24816F0829 | GOVERNMENT SCIENTIFIC SOURCE INC | 248-NETWORK CONTRACT OFFICE 8 | $3,980 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24814C0008_3600_-NONE-_-NONE- · retrieved 2026-09-26.